Dídia H Bismara Cury
- Serum calprotectin levels correlate with biochemical and histological markers of disease activity in TNBS colitisDídia Bismara Cury
Gastroenterology Department, Federal University of Sao Paulo, UNIFESP EPM, Brazil
Cell Immunol 282:66-70. 2013..Whether it correlates other markers of disease activity is unknown. The aim of this study was to correlate serum calprotectin with biochemical and histological measures of intestinal inflammation...
- Protective effect of octreotide and infliximab in an experimental model of indomethacin-induced inflammatory bowel diseaseDídia H Bismara Cury
Universidade de Sao Paulo, Sao Paulo, Brazil
Dig Dis Sci 53:2516-20. 2008....
- Infliximab to treat severe ulcerative colitisDídia Bisamra Cury
Department of Gastroenterology, Federal University of Sao Paulo, Rua Botucatu 740, Sao Paulo, SP 04023 900, Brazil
World J Gastroenterol 15:1771-3. 2009..We discuss findings in the literature regarding the use of infliximab therapy in patients with ulcerative colitis who have failed steroids and cyclosporine...
- Ocular manifestations in a community-based cohort of patients with inflammatory bowel diseaseDídia Bismara Cury
Center of Bowel Inflammatory diseases, Clinica Scope, Campo Grande MS, Brazil
Inflamm Bowel Dis 16:1393-6. 2010..The aim was to describe the spectrum of ophthalmologic conditions in patients with IBD in a community setting and to compare it with a control non-IBD cohort...